Europe PCR for Respiratory Infection Diagnostics Market

Market Introduction

Polymerase chain reaction (PCR) is used for accurate point-of-care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is generally preferred in inpatient and outpatient settings, which has helped improve the market's growth in recent years. The current outbreak of SARS CoV2 is boosting the growth of the market.

Europe PCR for Respiratory Infection Diagnostics Strategic Insights

Strategic insights for the Europe PCR for Respiratory Infection Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe PCR for Respiratory Infection Diagnostics Report Scope

Europe PCR for Respiratory Infection Diagnostics Regional Insights

The geographic scope of the Europe PCR for Respiratory Infection Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021. The market is anticipated to grow at a CAGR of 10.1% from 2021 to 2028. Increasing burden of chronic respiratory diseases (CRDs) and growing developments for PCR testing are expected to propel the growth of the market. However, availability of alternative assays is the major factor hindering the market growth.

Key Market Segments

In terms of type, the qPCR segment accounted for the highest share, and it is expected to dominate the largest market share in the coming future. The segment’s growth is majorly driven by its properties such as enormous dynamic range, remarkable sensitivity, ability to be very sequence-specific, little to no post-amplification processing, and increased sample throughput. Also, the regular developments for the PCR type are driving market.

Major Sources and Companies Listed

European Centre for Disease Prevention and Control, European Medicines Agency, European Respiratory Society, and Food and Drug Administration are among the major secondary sources for the Europe PCR for respiratory infection diagnostics market included in the report.

Reasons to Buy Report

• To understand the Europe PCR for respiratory infection diagnostics market landscape and identify market segments that are most likely to guarantee a strong return
• To stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe PCR for respiratory infection diagnostics market
• To efficiently plan M&A and partnership deals in the Europe PCR for respiratory infection diagnostics market by identifying market segments with the most promising probable sales
• To help in taking knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments that form the Europe PCR for respiratory infection diagnostics market
• To obtain market revenue forecast for market by various segments from 2021 to 2028 in the region

Europe PCR for Respiratory Infection Diagnostics Market Segmentation

by

Type

• Real-Time PCR (qPCR)
• Multiplex PCR
• Traditional PCR
• Digital PCR
• Reverse-Transcriptase (RT-PCR)
• Others

by Product Type

• Reagents and Kits
• Instruments
• Others

by Infection Type

• Bacterial Infections
  • Bordetella
  • Streptococcus Pneumoniae
  • Staphylococcus Aureus
  • Haemophilus Influenzae
  • Moraxella Catarrhalis
  • Mycoplasma Pneumoniae
  • Chlamydophila Pneumoniae
  • Legionella
  • Others
• Viral Infections
  • Rhinoviruses
  • Influenza Virus
  • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
  • Respiratory Syncytial Virus (RSV)
  • Adenovirus
  • Enterovirus
  • Parainfluenza
  • Human Metapneumovirus (hMPV)
  • Others
• Fungal and Other Pathogens

• by End User

• Hospitals
• Physician Clinics
• Clinical Laboratories
• Academic and Research Institutions
• Biotech and Pharma Companies
• Others

Company Profiles

• Abbott
• F. Hoffmann-LA Roche Ltd.
• Hologic, Inc.
• BD
• Bio-Rad Laboratories Inc.
• bioMerieux SA
• Qiagen
• Thermo Fisher Scientific Inc
• Seegene Inc
• AusDiagnostics